Partner With Us NRI

Benchmarks hit day`s high; realty shares slide

Published on Feb 18, 2022 13:28

The domestic equity barometers hit fresh intraday high in afternoon trade. The Nifty hovered around the 17,350 level. Realty stocks extended losses for the second consecutive session.

At 13:27 IST, the barometer index, the S&P BSE Sensex, was up 136.94 points or 0.24% to 58,028.95. The Nifty 50 index gained 43.60 points or 0.25% at 17,348.90.

Coal India (up 2.76%), SBI Life (up 2.74%), HDFC (up 1.34%), Grasim (up 1.01%) and SBI (up 0.90%) were the top index gainers.

Cipla (down 2.22%), ONGC (down 2.10%), Divi`s Lab (down 1.92%), Ultratech Cement (down 1.50%) and Shree Cement (down 1.31%) were the top index losers.

In the broader market, the S&P BSE Mid-Cap index fell 0.28% while the S&P BSE Small-Cap index slipped 0.18%.

The market breadth was negative. On the BSE, 1,388 shares rose and 1,883 shares fell. A total of 121 shares were unchanged.

Buzzing Index:

The Nifty Realty index slipped 0.31% to 453.30. The index has lost 0.55% in two sessions.

Indiabulls Real Estate (down 1.53%), Sobha Developers (down 1.15%), Sunteck Realty (down 0.96%), DLF (down 0.88%), The Phoenix Mills (down 0.71%), Brigade Enterprises (down 0.70%) and Godrej Properties (down 0.68%) declined.

Stocks in Spotlight:

Ambuja Cements dropped 5.13% to Rs 340.95. The company recorded 49.4% fall in standalone net profit to Rs 252 crore despite a 6.1% increase in net sales to Rs 3,679 crore in Q4 CY2021 over Q4 CY2020. Sales volume (cement + clinker) in Q4 CY21 was 7.2 million tons (up 3% Y-o-Y).

Hero MotoCorp added 0.78% to Rs 2799.05. The two-wheeler major has inaugurated its new dealership - Surya Hero in Jaipur, Rajasthan. Surya Hero will act as a one-stop-shop for all the sales and customer service requirements, in addition to offering the latest range of Hero-branded merchandise and accessories at the dealership.

Lupin shed 0.23% to Rs 769.75. The company, on Thursday, announced that the USFDA has approved the company`s supplemental New Drug Application to expand the use of SOLOSEC (secnidazole) in the treatment of bacterial vaginosis.

Powered by Capital Market - Live News